Stability Study Considerations Throughout the Drug Product Life Cycle
Our expert, Megan Doran, Formulation Team Leader at Intertek Melbourn, takes you on a journey of stability study considerations throughout the drug product life cycle highlighting key challenges and analytical testing considerations from discovery and preclinical all the way to monitoring continued product performance throughout the shelf set shelf life of the drug product for commercial batches.
Meet our expert:
Megan is our Formulation Team Leader. She has nearly a decade of experience working on analytical testing, with a particular focus on inhaled product testing. In her time at Intertek, she has worked with a variety of different clients, helping to compile information critical to regulatory submissions. Recently her focus has been on the formulation development of inhaled products, leading a variety of projects from initial formulation screening and development to the manufacture of products for Phase I/II clinical trials.